CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”
Medtronic closes Scientia Vascular takeover, continuing M&A streak
Medtronic closes Scientia Vascular takeover, continuing M&A streak is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive